These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8927037)

  • 1. In vivo effects of peroxovanadium compounds in BB rats.
    Yale JF; Vigeant C; Nardolillo C; Chu Q; Yu JZ; Shaver A; Posner BI
    Mol Cell Biochem; 1995 Dec 6-20; 153(1-2):181-90. PubMed ID: 8927037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoglycemic effects of peroxovanadium compounds in Sprague-Dawley and diabetic BB rats.
    Yale JF; Lachance D; Bevan AP; Vigeant C; Shaver A; Posner BI
    Diabetes; 1995 Nov; 44(11):1274-9. PubMed ID: 7589823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxovanadium compounds. A new class of potent phosphotyrosine phosphatase inhibitors which are insulin mimetics.
    Posner BI; Faure R; Burgess JW; Bevan AP; Lachance D; Zhang-Sun G; Fantus IG; Ng JB; Hall DA; Lum BS
    J Biol Chem; 1994 Feb; 269(6):4596-604. PubMed ID: 8308031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the glucose-lowering properties of vanadyl sulfate and bis(maltolato)oxovanadium(IV) following acute and chronic administration.
    Yuen VG; Orvig C; McNeill JH
    Can J Physiol Pharmacol; 1995 Jan; 73(1):55-64. PubMed ID: 7600453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hypoglycemic effects of bis(maltolato)oxovanadium administered by different routes upon diabetic rats].
    Zhong XY; Zhang H; Zhang X; Lv WL; Zhang Q
    Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Jun; 36(3):313-8. PubMed ID: 15205708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vanadium compounds as insulin mimics.
    Orvig C; Thompson KH; Battell M; McNeill JH
    Met Ions Biol Syst; 1995; 31():575-94. PubMed ID: 8564818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-diabetic effects of vanadium(III, IV, V)-chlorodipicolinate complexes in streptozotocin-induced diabetic rats.
    Li M; Ding W; Smee JJ; Baruah B; Willsky GR; Crans DC
    Biometals; 2009 Dec; 22(6):895-905. PubMed ID: 19404749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of vanadium treatment on bone in diabetic and non-diabetic rats.
    Facchini DM; Yuen VG; Battell ML; McNeill JH; Grynpas MD
    Bone; 2006 Mar; 38(3):368-77. PubMed ID: 16256449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Administration of optimum sustained-insulin release PLGA microcapsules to spontaneous diabetes-prone BB/Wor//Tky rats.
    Takenaga M; Yamaguchi Y; Ogawa Y; Kitagawa A; Kawai S; Mizushima Y; Igarashi R; Namae M; Komeda K
    Drug Deliv; 2006; 13(2):149-57. PubMed ID: 16423804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 activity exerts an antidiabetic action in Goto-Kakizaki rats.
    Abella A; Marti L; Camps M; Claret M; Fernández-Alvarez J; Gomis R; Gumà A; Viguerie N; Carpéné C; Palacín M; Testar X; Zorzano A
    Diabetes; 2003 Apr; 52(4):1004-13. PubMed ID: 12663473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anti-diabetic effects and pharmacokinetic profiles of bis(maltolato)oxovanadium in non-diabetic and diabetic rats.
    Zhang SQ; Zhong XY; Chen GH; Lu WL; Zhang Q
    J Pharm Pharmacol; 2008 Jan; 60(1):99-105. PubMed ID: 18088510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effects of various vanadium salts on glucose homeostasis in streptozotocin-diabetic rats.
    Becker DJ; Ongemba LN; Henquin JC
    Eur J Pharmacol; 1994 Aug; 260(2-3):169-75. PubMed ID: 7988641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic phosphotyrosine phosphatase activity and its alterations in diabetic rats.
    Meyerovitch J; Backer JM; Kahn CR
    J Clin Invest; 1989 Sep; 84(3):976-83. PubMed ID: 2547842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of vanadium complexes with organic ligands on glucose metabolism: a comparison study in diabetic rats.
    Reul BA; Amin SS; Buchet JP; Ongemba LN; Crans DC; Brichard SM
    Br J Pharmacol; 1999 Jan; 126(2):467-77. PubMed ID: 10077240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transdermally delivered peroxovanadium can lower blood glucose levels in diabetic rats.
    Brand RM; Hamel FG
    Int J Pharm; 1999 Jun; 183(2):117-23. PubMed ID: 10361162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The protein tyrosine phosphatase inhibitor, pervanadate, is a powerful antidiabetic agent in streptozotocin-treated diabetic rats.
    Shisheva A; Ikonomov O; Shechter Y
    Endocrinology; 1994 Jan; 134(1):507-10. PubMed ID: 8275968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term bioaccumulation of vanadium when ingested with a tea decoction in streptozotocin-induced diabetic rats.
    Edel AL; Kopilas M; Clark TA; Aguilar F; Ganguly PK; Heyliger CE; Pierce GN
    Metabolism; 2006 Feb; 55(2):263-70. PubMed ID: 16423636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syntheses of vanadyl and zinc(II) complexes of 1-hydroxy-4,5,6-substituted 2(1H)-pyrimidinones and their insulin-mimetic activities.
    Yamaguchi M; Wakasugi K; Saito R; Adachi Y; Yoshikawa Y; Sakurai H; Katoh A
    J Inorg Biochem; 2006 Feb; 100(2):260-9. PubMed ID: 16387366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxovanadium compounds: biological actions and mechanism of insulin-mimesis.
    Bevan AP; Drake PG; Yale JF; Shaver A; Posner BI
    Mol Cell Biochem; 1995 Dec 6-20; 153(1-2):49-58. PubMed ID: 8927047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal study of first phase insulin release in the BB rat.
    Reddy S; Bibby NJ; Fisher SL; Elliott RB
    Diabetologia; 1986 Nov; 29(11):802-7. PubMed ID: 3545956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.